Diphenydramine

DRUG2 trials

Sponsors

Stanford University, Genzyme, a Sanofi Company

Conditions

Blood CancerCLLGraft Versus Host DiseaseHodgkin's DiseaseLeukemiaMDSMalignancyMultiple Sclerosis

Phase 2

Allogeneic Transplantation From Related Haploidentical Donors

CompletedNCT00185692

Stanford UniversityBlood Cancer, CLL, Graft Versus Host Disease +5

Start: 2000-08-31End: 2010-12-31Updated: 2019-12-04

Phase 3

A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT

TerminatedNCT03368664

Genzyme, a Sanofi CompanyMultiple Sclerosis

Start: 2017-10-24End: 2025-09-08Updated: 2025-11-26